Transplantation of the spleen: Effect of splenic allograft in human multivisceral transplantation

Annals of Surgery

Volumn 246, Issue 3, 2007, Pages 436-444

  Kato, Tomoaki ^a   Tzakis, Andreas G ^a   Selvaggi, Gennaro ^a   Gaynor, Jeffrey J ^a   Takahashi, Hidenori ^a   Mathew, James ^a   Garcia Morales, Rolando ^a   Hernandez, Erick ^a   David, Andre ^a   Nishida, Seigo ^a   Levi, David ^a   Moon, Jang ^a   Island, Eddie ^a   Kleiner, Gary ^a   Ruiz, Phillip ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; CHILD; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMOLYSIS; HUMAN; INCIDENCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVISCERAL TRANSPLANTATION; ORGAN DONOR; PRIORITY JOURNAL; SPLEEN TRANSPLANTATION; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; BLOOD CELL COUNT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; INFANT; LENGTH OF STAY; LYMPHOPROLIFERATIVE DISORDERS; MALE; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; SPLEEN; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VISCERA;

EID: 34548171017     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181485124     Document Type: Article

References (36)

1. Hansen K, Singer DB. Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited. Pediatr Dev Pathol. 2001;4:104-121.
2. Spencer J, Perry ME, Dunn-Walters DK. Human marginal-zone B cells. Immunol Today. 1998;19:421-426.
3. Sullivan JL, Ochs HD, Schiffman G, et al. Immune response after splenectomy. Lancet. 1978;1:178-181.
4. Leonard AS, Giebink GS, Baesl TJ, et al. The overwhelming postsplenectomy sepsis problem. World J Surg. 1980;4:423-432.
5. Tzakis AG, Kato T, Levi DM, et al. 100 multivisceral transplants at a single center. Ann Surg. 2005;242:480-493.
6. Kato T, Tzakis A, Selvaggi G, et al. Intestinal and mutivisceral transplantation in children. Ann Surg. 2006;243:756-764.
7. Bitter-Suermann H. Survival of unmodified spleen allografts in rats. Nature. 1974;247:465-466.
8. Suzuki H, Li XH, Miyamoto M, et al. Induction of transplantation tolerance in adult rats by vascularized spleen transplantation. Transplantation. 1997;64:650-654.
9. Bitter-Suermann H. Prolonged survival of auxiliary spleen allografts in rats inducing acceptance of skin allografts. Transplantation. 1974;17:75-83.
10. Bitter-Suermann H, Save-Soderbergh J. The course of pancreas allografts in rats conditioned by spleen allografts. Transplantation. 1978;26:28-34.
11. Duncan WR, Stepkowski SM, Bitter-Suermann H. Induction of transplantation in rats by spleen allografts. I. Evidence that rats tolerant of spleen allografts contain two fenotypically distinct T suppressor cells. Transplantation. 1986;41:626-633.
12. Duncan WR, Bitter-Suermann H, Stepkowski SM. Induction of transplantation tolerance in rats by spleen allografts. III. The role of T suppressor cells in the induction of specific unresponsiveness. Transplantation. 1987;44:553.
13. Stepkowski SM. Bitter-Suermann H. Dukan WR. Evidence supporting an in vivo role for T suppressor cells in spleen allograft induced tolerance. Transplant Proc. 1986;18:207.
14. Marchioro TL, Rowlands DT, Rifkind D, et al. Splenic homotransplantation. Ann NY Acad Sci. 1964;120:626.
15. Hathaway WE, Mull MM, Githens JH, et al. Attempted spleen transplant in classical hemophilia. Transplantation. 1969;7:73-75.
16. Xia SS, Jiang HC, Zhou XX, He G. Treatment of hemophilia A by living mother-to-son splenic transplantation. First case report in the world. Chin Med J (Engl). 1992;105:609-611.
17. Xiang WZ, Jie ZW, Sheng XS. Clinical observation on hemophilia A treatment by cadaveric spleen transplantation. Transplant Proc. 2002;34:1929-1931.
18. Groth CG, Blomstrand R, Dreborg S, et al. Splenic transplantation in Gaucher disease. Birth Defects Orig Artic Ser. 1973;9:102-105.
19. Groth CG, Dreborg S, Ockerman PA, et al. Splenic transplantation in a case of Gaucher's disease. Lancet. 1971;1:1260-1264.
20. Raccuglia G, Lansing A. Spleen transplantation in a leukaemic individual from his healthy identical twin. Clin Exp Immunol. 1973;14:1-18.
21. Liu DL, Xia S, Tang J, et al. Allotransplantation of whole spleen in patients with hepatic malignant tumors or hemophilia A. Operative technique and preliminary results. Arch Surg. 1995;130:33-39.
22. Starzl TE, Iwatsuki S, Shaw BW Jr, et al. Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet. 1984;159:26S.
23. Deierhoi MH, Sollinger HW, Bozdech MJ, et al. Lethal graft-versus-host disease in a recipient of a pancreas spleen transplant. Transplantation. 1986;41:544-546.
24. Gonwa TA, Goeken NE, Schulak JA, et al. Failure of cyclosporine to prevent in vivo T cell priming in man. Studies in allogeneic spleen transplantation. Transplantation. 1985;40:299-304.
25. Booster MH, Wijnen RM, van Hooff JP, et al. The role of the spleen in pancreas transplantation. Transplantation. 1993;56:1098-1102.
26. Dor FJMF, Gollackner B, Cooper DKC. Can spleen transplantation induce tolerance? A review of the literature. Transpl Int. 2003;16:451-460.
27. Dor FJMF, Cooper DKC. Immunologic benefits of spleen transplantation in the absence of graft-versus-host disease. Ann Surg. 2006;243:710-711.
28. Kato T, Ruiz P, Thompson J, et al. Intestinal and multivisceral transplantation. Word J Surg. 2002;26:226-237.
29. Kato T, Tzakis A. Transplantation of the liver with digestive organs. In: Busuttil, Klintmalm, eds. Transplantation of Liver. 2nd ed. Philadelphia, PA: Elsevier-Saunders; 2005:787-802.
30. Mittal NK, Tzakis AG, Kato T, et al. Current status of small bowel transplantation in children: update 2003. Pediatr Clin North Am. 2003;50:1419-1433.
31. Garcia-Morales R, Carreno M, Mathew JM, et al. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. J Clin Invest. 1997;99:1118-1129.
32. Fehervari Z, Sakaguchi S. CD4+ T regs and immune control. J Clin Invest. 2004;114:1209-1217.
33. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345-352.
34. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 2003;361:1502-1510.
35. Panaro F, DeChristopher PJ, Rondelli D, et al. Severe hemolytic anemia due to passenger lymphocytes after living-related bowel transplant. Clin Transplant. 2004;18:332-335.
36. Brunner B, Kropshofer G, Ellemunter H, et al. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient. Pediatr transplant. 2007; doi:10. 1111/j. 1399-3046. 2007. 00711.